1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with tosylphenylalanyl chloromethyl ketone in 3 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (tosylphenylalanyl chloromethyl ketone) | Trials (tosylphenylalanyl chloromethyl ketone) | Recent Studies (post-2010) (tosylphenylalanyl chloromethyl ketone) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 529 | 0 | 69 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | tosylphenylalanyl chloromethyl ketone (IC50) |
|---|---|---|---|
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 0.64 | |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | 2.18 | |
| perilipin-5 | Homo sapiens (human) | 1.901 | |
| perilipin-1 | Homo sapiens (human) | 1.868 | |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | 1.8845 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.37 | |
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 3.8 | |
| Chymase | Homo sapiens (human) | 3.3 | |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 3.8 | |
| Transcription factor p65 | Homo sapiens (human) | 3.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kantorski, J; Tchórzewski, H | 1 |
| Choi, IW; Choi, JH; Chung, WJ; Han, SJ; Han, SS; IM, SY; Jang, KY; Lee, DG; Lee, HB; Lee, HK; Park, KH | 1 |
| Dohi, T; Kitayama, S; Kurihara, H; Mizuno, N; Morita, K; Shibata, K; Shinohara, H; Yoshino, H | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and tosylphenylalanyl chloromethyl ketone
| Article | Year |
|---|---|
The effect of serine and thiol protease inhibitors on the chemiluminescence of human neutrophils in investigations in vitro.
Topics: Calcimycin; Cysteine Proteinase Inhibitors; Humans; In Vitro Techniques; Luminescent Measurements; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Respiratory Burst; Serine Proteinase Inhibitors; Tetradecanoylphorbol Acetate; Tosylarginine Methyl Ester; Tosyllysine Chloromethyl Ketone; Tosylphenylalanyl Chloromethyl Ketone; Tyrosine; Zymosan | 1992 |
Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB.
Topics: Acetylcysteine; Animals; Antioxidants; Azepines; Benzoquinones; Disseminated Intravascular Coagulation; DNA-Binding Proteins; Female; Gene Expression Regulation; Genistein; Hemorrhage; Hydrogen Peroxide; I-kappa B Proteins; Isoflavones; Kidney Medulla; Lactams, Macrocyclic; Lethal Dose 50; Macrophages; Mice; Mice, Inbred C57BL; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Platelet Activating Factor; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Pulmonary Edema; Pyrrolidines; Quinones; Reactive Oxygen Species; Rifabutin; Serine Proteinase Inhibitors; Signal Transduction; Specific Pathogen-Free Organisms; Succinic Acid; Thiocarbamates; Tosylphenylalanyl Chloromethyl Ketone; Triazoles; Tumor Necrosis Factor-alpha; Vitamin E | 2000 |
Mediation by platelet-activating factor of 12-hydroxyeicosatetraenoic acid-induced cytosolic free calcium concentration elevation in neutrophils.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Azepines; Calcium; Cytosol; Enzyme Inhibitors; Humans; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rabbits; Terpenes; Tosylphenylalanyl Chloromethyl Ketone; Triazoles | 2000 |